Kraig Biocraft Laboratories Successfully Completes March/April Production Cycle; May Production Now Underway
Kraig Biocraft Laboratories (OTCQB: KBLB), a biotechnology company specializing in spider silk technology, has announced the successful completion of its March/April spider silk production cycle and the commencement of its May production run. The company reports meeting internal performance benchmarks and production targets, demonstrating progress in its 2025 production scale-up plan.
The achievement builds upon operational and technical advancements from 2024, with production activities in both Vietnam and the U.S. showing consistent execution. This progress supports Kraig Labs' strategy to transition from pilot-scale to commercial-scale production of recombinant spider silk for multiple markets.
Kraig Biocraft Laboratories (OTCQB: KBLB), un'azienda biotecnologica specializzata nella tecnologia della seta di ragno, ha annunciato il completamento con successo del ciclo di produzione di seta di ragno di marzo/aprile e l'inizio della produzione di maggio. L'azienda segnala di aver raggiunto gli obiettivi interni di performance e produzione, dimostrando progressi nel piano di espansione produttiva previsto per il 2025.
Questo risultato si basa sui miglioramenti operativi e tecnici ottenuti nel 2024, con attività produttive sia in Vietnam che negli Stati Uniti che hanno mostrato una esecuzione costante. Questo progresso supporta la strategia di Kraig Labs di passare dalla produzione pilota alla produzione commerciale di seta di ragno ricombinante per diversi mercati.
Kraig Biocraft Laboratories (OTCQB: KBLB), una empresa biotecnológica especializada en tecnología de seda de araña, ha anunciado la finalización exitosa de su ciclo de producción de seda de araña de marzo/abril y el inicio de la producción de mayo. La compañía informa haber cumplido con los objetivos internos de rendimiento y producción, demostrando avances en su plan de aumento de producción para 2025.
Este logro se basa en los avances operativos y técnicos de 2024, con actividades productivas tanto en Vietnam como en Estados Unidos mostrando una ejecución constante. Este progreso respalda la estrategia de Kraig Labs para pasar de la producción a escala piloto a la producción a escala comercial de seda de araña recombinante para múltiples mercados.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 거미줄 기술을 전문으로 하는 생명공학 회사로, 3월/4월 거미줄 생산 주기를 성공적으로 완료하고 5월 생산을 시작했다고 발표했습니다. 회사는 내부 성능 기준과 생산 목표를 달성했으며, 2025년 생산 확대 계획에 진전을 보였다고 보고했습니다.
이번 성과는 2024년의 운영 및 기술적 발전을 기반으로 하며, 베트남과 미국에서의 생산 활동이 일관되게 진행되고 있습니다. 이 진전은 Kraig Labs가 여러 시장을 위한 재조합 거미줄의 파일럿 규모 생산에서 상업적 규모 생산으로 전환하는 전략을 지원합니다.
Kraig Biocraft Laboratories (OTCQB : KBLB), une entreprise de biotechnologie spécialisée dans la technologie de la soie d'araignée, a annoncé l'achèvement réussi de son cycle de production de soie d'araignée de mars/avril et le démarrage de la production de mai. L'entreprise rapporte avoir atteint ses objectifs internes de performance et de production, démontrant des progrès dans son plan d'augmentation de la production pour 2025.
Cette réussite s'appuie sur les avancées opérationnelles et techniques de 2024, avec des activités de production au Vietnam et aux États-Unis montrant une exécution constante. Ce progrès soutient la stratégie de Kraig Labs visant à passer de la production à l'échelle pilote à la production commerciale de soie d'araignée recombinante pour plusieurs marchés.
Kraig Biocraft Laboratories (OTCQB: KBLB), ein Biotechnologieunternehmen, das sich auf Spinnenseidentechnologie spezialisiert hat, hat den erfolgreichen Abschluss seines Produktionszyklus für Spinnenseide im März/April bekannt gegeben und den Produktionslauf im Mai gestartet. Das Unternehmen berichtet, interne Leistungskennzahlen und Produktionsziele erreicht zu haben, was Fortschritte im Produktionsausbauplan für 2025 zeigt.
Der Erfolg baut auf betrieblichen und technischen Verbesserungen aus dem Jahr 2024 auf, wobei die Produktionsaktivitäten sowohl in Vietnam als auch in den USA eine konstante Umsetzung zeigen. Dieser Fortschritt unterstützt die Strategie von Kraig Labs, von der Pilotproduktion auf die kommerzielle Produktion von rekombinanter Spinnenseide für mehrere Märkte umzusteigen.
- Production targets and internal performance benchmarks were met for March/April cycle
- Company remains on track to meet full-year production capacity goals
- Successfully expanding manufacturing capabilities across Vietnam and U.S. operations
- None.
Company Continues to Meet 2025 Scale-Up Targets
ANN ARBOR, Mich., May 06, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that it has successfully completed its March/April spider silk production run and is currently well underway with its May production cycle.
This steady progress reflects the Company's continued execution against its 2025 production scale-up plan, which builds on the significant operational and technical advancements achieved throughout 2024. Spider silk production for March and April met internal performance benchmarks and production targets, reinforcing confidence in the expanded capacity and workflow improvements implemented earlier this year.
With May's production already in progress, Kraig Labs is maintaining its momentum and remains on track to meet its full-year production capacity goals. These efforts support Kraig Labs' broader strategy to transition recombinant spider silk from pilot-scale production to commercial viability across multiple markets.
"Our teams in Vietnam and the U.S. continue to demonstrate consistent execution and focus," said Company Founder and CEO, Kim Thompson. "With each completed cycle, we are strengthening our manufacturing capabilities and moving closer to our goal of delivering commercial volumes of eco-friendly, performance fiber."
The Company will provide further updates as it progresses through its 2025 production calendar.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/470ab210-4578-4921-bb49-d7cd57ea36ba
FAQ
What did Kraig Biocraft Laboratories (KBLB) announce about its production cycles in May 2025?
Where does Kraig Biocraft Laboratories (KBLB) conduct its spider silk production operations?
What are Kraig Biocraft Laboratories' (KBLB) production goals for 2025?
Who is the CEO of Kraig Biocraft Laboratories (KBLB)?
